No Data
Medikey (688079.SH): The RF chip BAW project, multi-channel chromatographic chip optical path layer and other products are under development and testing, and the full process of sample preparation has been achieved.
On November 25th, Gelonghui reported that Medike (688079.SH) stated on the investor interaction platform that since its listing, the company has been committed to enriching and perfecting its business structure. Based on its existing optical products, it has placed significant investments in fields such as semiconductor acousto-optics, semiconductor micro-nano circuits, semiconductor packaging and testing, and micro-nano optics. Currently, products such as the complete acoustic layer solution for ultrasonic fingerprint chips, the complete optical path solution for ambient light chip products, the complete optical path solution for CIS image sensors, and the wafer manufacturing and packaging for RF chip SAW have gradually achieved mass production. Additionally, projects for RF chip BAW and multi-channel color...
Meidikai (688079.SH): temporarily no applications related to optical chips for the product.
On November 25th, Gelonhui reported that Medikai (688079.SH) stated on the investor interaction platform that the company's products currently do not have any applications related to optical chips.
October 31st A-share investment lightning rod | Medikai: Shareholder Fengsheng Jiamei plans to reduce their shareholding by no more than 3%; *Special Treat Ningke: and the actual controller received a notice from the China Securities Regulatory Commission
Hontian shareholders Dawson Investment and Nord Technology plan to reduce their shareholdings by a total of no more than 5%; Meidikai's shareholder Fengsheng Jiamei plans to reduce its shareholding by no more than 3%; Chongqing Iron & Steel incurs a net loss of 1.35 billion yuan in the first three quarters; Risesun Real Estate Development incurs a net loss of 1.425 billion yuan in the first three quarters; Longi Green Energy Technology incurs a net loss of 6.505 billion yuan in the first three quarters; Kraussmaffei incurs a net loss of 1.079 billion yuan in the first three quarters; Ruitai Materials Technology terminates the planned restructuring; ST Ningke and the actual controller received a notice of filing from the China Securities Regulatory Commission.
Hangzhou Medikai Optoelectronics Technology Co., Ltd. Report for the Third Quarter of 2024
MedSci (688079.SH) released its performance for the first three quarters, with a net loss of 64.4378 million yuan.
Meidikai (688079.SH) released the third quarter report for the year 2024, achieving revenue of 3...
There's Reason For Concern Over Hangzhou Mdk Opto Electronics Co.,Ltd.'s (SHSE:688079) Massive 29% Price Jump
There's Reason For Concern Over Hangzhou Mdk Opto Electronics Co.,Ltd's (SHSE:688079) Massive 35% Price JumpNo Data
No Data
